<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00895427</url>
  </required_header>
  <id_info>
    <org_study_id>VL-2709</org_study_id>
    <nct_id>NCT00895427</nct_id>
  </id_info>
  <brief_title>A Study Comparing Skin Fluorescence to Coronary Artery Calcification</brief_title>
  <acronym>CACS</acronym>
  <official_title>A Cross-Sectional Study Comparing Noninvasive Skin Fluorescence to Coronary Artery Calcification Measured by Rapid Computed Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VeraLight, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>New Mexico Heart Institute, PA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VeraLight, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study examines the relationship between the SCOUT DM device and coronary artery
      calcification as determined by rapid computed tomography in patients at risk for coronary
      heart disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cross-sectional, single site, cohort screening trial. The correlation between the
      measured skin fluorescence and the CACS will be determined using a design that includes
      stratification by gender, subject age and subject CAC score. This design requires a single
      patient visit to the clinical site and a single measurement on the SCOUT device.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>12</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Diabetes</condition>
  <condition>Coronary Artery Calcification</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Male ages 45-54, without diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Male ages 55-64, without diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Male ages 65+, without diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Male ages 45-54, with diabetes and CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <description>Male ages 55-64, with diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <description>Male ages 65+, with diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>7</arm_group_label>
    <description>Female ages 50-59, without diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>8</arm_group_label>
    <description>Females ages 60-69, without diabetes and CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>9</arm_group_label>
    <description>Females ages 70 +, without diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10</arm_group_label>
    <description>Female ages 50- 59, with diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>11</arm_group_label>
    <description>Female ages 60-69, with diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12</arm_group_label>
    <description>Female age 70+, with diabetes, CAC score from 0 to &gt;1000</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects are sorted into the follwoing categories for age (years): men:45-54,55-64,65+,
        women: 50-59, 60-69, 70+. In addition, subjects will be sorted into the follwoing
        categories for CACS:0-10, 11-100, 101-400, 401-1000, &gt;1000 and absence/presence of
        diagnosed diabetes (type 1 or type 2)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males ≥ 45 years or females ≥ 50 years old that have had a coronary artery
             calcification score determined by rapid computed tomography at the clinical site
             within the last six months.

        Exclusion Criteria:

          -  Receiving investigational treatments

          -  Psychosocial issues that interfere with an ability to follow study procedures

          -  Known to be pregnant

          -  Receiving dialysis or having known renal compromise

          -  Scars, tattoos, rashes or other disruption/discoloration on the left volar forearm.

          -  Recent or current oral steroid therapy or topical steroids applied to the left forearm

          -  Current chemotherapy, or chemotherapy within the past 12 months

          -  Receiving medications that fluoresce*

          -  Known to have, or at risk for, photosensitivity reactions ( e.g., sensitive to
             ultraviolet light, or taking medication known to cause photosensitivity)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Maynard, MS</last_name>
    <role>Study Director</role>
    <affiliation>VeraLight, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New Mexico Heart Institute</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2009</study_first_submitted>
  <study_first_submitted_qc>May 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2009</study_first_posted>
  <last_update_submitted>October 7, 2011</last_update_submitted>
  <last_update_submitted_qc>October 7, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary artery calcification</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcinosis</mesh_term>
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

